Geo News
Community curated by people like you
Latest
AI
Crypto
Health
World Affairs
US Politics
STAT+: AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion
Statnews
View source article
STAT+: AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion — Statnews
Featured Stories
OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns
Aug 7, 2026
·
2 sources
